Seven days of antibiotics was noninferior to 14 days for treating Gram-negative bloodstream infections, supporting shorter ...

Antimicrobial resistance not only undermines the efficacy of current treatments but also endangers the entirety of modern ...

Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya to treat uUTIs.

Scientists have demonstrated that select human gut bacteria can bioaccumulate and sequester PFAS ‘forever chemicals’, ...

Researchers have long known that glycosaminoglycan-binding proteins (HBPs) help control vital processes like cell growth, inflammation, and blood clotting. But a recent discovery has revealed a hidden ...

This paper reports the fabrication of a sensor using ZnO nanorods for detection of two bacterial pathogens, namely Escherichia coli, which is a gram-negative bacteria and Streptococcus pneumonia, ...

Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ribosomal site.

The Plan Tam plans to first identify useful antibiotic combinations against multidrug resistant bacteria and then validate the mathematical model predictions with clinical outcomes. He will use three ...

Antibiotic resistance is a major challenge in modern medicine. The unique double membrane structure of Gram-negative bacteria limits the efficacy of many existing antibiotics and adds complexity to ...

In what they labeled a "surprising" finding, Johns Hopkins Medicine researchers studying bacteria from freshwater lakes and soil say they have determined a protein's essential role in maintaining the ...